An aldose reductase inhibitor
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
AT-001 is an inhibitor of aldose reductase (IC50 = 28.9 pM).1 It reduces infarct area in streptozotocin-induced diabetic mice expressing human aldose reductase in a model of cardiomyopathy induced by ischemia-reperfusion injury when administered at a dose of 40 mg/kg.2
1.Wasmuth, A., Landry, D., Deng, S.X., et al.Aldose reductase inhibitors and uses thereof(2014) 2.Perfetti, R., Rowell, P., Shendelman, S., et al.Preclinical and clinical proof of concept for metabolic intervention in diabetic cardiomyopathyJ. Card. Fail.25(8)S77(2019)
没有评价数据